ORTHO REGENERATIVE TECHNOLOGIES INC.
Regenerative orthopedic procedures using cell-based therapy for joint and musculoskeletal repair
- Sector
- Medtech
- Headquarters
- KIRKLAND, A8
- Founded
- 2015
- Latest Form D
- $73K, Oct 2020
- Total capital
- $123K
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $123K
- 2 Form D · last Oct 2020
- 72 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 3 pending · first 2022
- Rank in peer group#1178 of 4516
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$73K
- Private capital raisedForm D · SEC · 1st filing$50K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 4516 peers
Line = medianMedtech · Service
- Granted patents#1178 · top 26%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Caroline HoemannResearcherDirectorLinked by 1 patent
- Brent ES NortonDirectorNamed in SEC Form D filings
- Guy Paul ES AllardExecutive OfficerNamed in SEC Form D filings
- Jo-Anne ES Mainguy-PicheExecutive OfficerNamed in SEC Form D filings
- Laurence ES RulleauDirectorNamed in SEC Form D filings
- LeDuc ClaudeExecutive Officer, DirectorNamed in SEC Form D filings
Show all 12 people
- Luc ES MainvilleExecutive OfficerNamed in SEC Form D filings
- Michael AtkinDirectorNamed in SEC Form D filings
- Michael BuschmannDirectorNamed in SEC Form D filings
- Pierre ES LaurinDirectorNamed in SEC Form D filings
- Steve SaviukDirectorNamed in SEC Form D filings
- Tom ES WrightDirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 5- PendingLyophilized Polymer Scaffold Compositions, Processes For Preparation And Use In Anabolic Wound RepairUSPTOApplication 18512129
- GrantedLyophilized Polymer Scaffold Compositions, Processes For Preparation And Use In Anabolic Wound RepairUSPTOUS 11,844,874
- PendingFreeze-dried Polymer Compositions For Mixing With Platelet Rich Plasma To Form Implants For Tissue Repair And/or Compositions For Therapeutic Intra-articular InjectionsUSPTOApplication 17665753
Show all 5 patent records
- Lyophilized Polymer Scaffold Compositions, Processes For Preparation And Use In Anabolic Wound RepairApr 11, 2024 · Application 18512129Pending
- Lyophilized Polymer Scaffold Compositions, Processes For Preparation And Use In Anabolic Wound RepairDec 19, 2023 · US 11,844,874Granted
- Freeze-dried Polymer Compositions For Mixing With Platelet Rich Plasma To Form Implants For Tissue Repair And/or Compositions For Therapeutic Intra-articular InjectionsMay 19, 2022 · Application 17665753Pending
- Freeze-dried Polymer Compositions For Mixing With Platelet Rich Plasma To Form Implants For Tissue Repair And/or Compositions For Therapeutic Intra-articular InjectionsMar 29, 2022 · US 11,285,100Granted
- Novel Formulation Of Physiological Chitosan-inorganic Salt Solution/blood Mixtures For Tissue RepairNov 23, 2017 · Application 15629795Pending
Related companies, and why
- Major Medical Devices, LLCSimilar federal contract value in Medtech · null in contracts
- Resonant Link Medical, Inc.Similar federal contract value in Medtech · null in contracts
- Platform Innovations Inc.Similar federal contract value in Medtech · null in contracts
- Concept Medical, Inc.Similar federal contract value in Medtech · null in contracts
- Geneticure Inc.Similar federal contract value in Medtech · null in contracts
- Voyce, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .